Jan. 08 Pre-market Movers Board: Boeing plunges 8% premarket after an explosion occurred on Boeing 737 MAX 9 last Friday
Seize the market opportunities with us at 8:45 every morning, and don't forget to check our "Lunchtime Movers Board" at 12:00.
Premarket Gainers: Harpoon, Vincerx, Heron, Annexon, Molecular
HARP:
HarpoonTherapeutics rockets 102% premarket after reported Merck in talks to buy the Co. for $700M.
VINC:
VincerxPharma soars 59% premarket after announcing compelling clinical efficacy of Enitociclib in combination with Venetoclax and prednisone in lymphoma.
HRTX:
HeronTherapeutics surges 12% premarket after announcing partnership with Crosslink life sciences to expand promotional effort for ZYNRELEF.
ANNX:
Annexon climbs 10% premarket after outlines priorities with late-stage clinical milestones across upstream complement portfolio for autoimmune, ophthalmic and neurodegenerative diseases.
MOLN:
Molecular spikes 5% as the Co. to provide updates at 42nd annual JPM Healthcare conference.
Premarket Losers: LumiraDx, Spirit, Boeing, Alaska Air, XPeng
LMDX: LumiraDx plunges 29% premarket after announcing its securities will be suspended from trading on Nasdaq.
SPR:
Spirit Aerosystems drops 15% premarket under the effect of Boeing 737 Max explosion.
BA:
Boeing plunges 8% premarket after The FAA required all Boeing 737 MAX 9 aircraft operated within US to be temporarily grounded and undergo safety inspections.
ALK:
Alaska Air sinks 5% premarket after an explosion occurred on one of the company's Boeing 737 MAX 9 aircraft last Friday.
XPEV:
XPeng sinks 5% premarket after JPM sold HK$334M of the Co.'s HK-listed shares.
$HARP(HARP)$VINC(VINC)$HRTX(HRTX)$ANNX(ANNX)$MOLN(MOLN)$LMDX(LMDX)$SPR(SPR)$BA(BA)$ALK(ALK)$XPEV(XPEV)